Literature DB >> 24984779

Writers and readers of histone acetylation: structure, mechanism, and inhibition.

Ronen Marmorstein1, Ming-Ming Zhou2.   

Abstract

Histone acetylation marks are written by histone acetyltransferases (HATs) and read by bromodomains (BrDs), and less commonly by other protein modules. These proteins regulate many transcription-mediated biological processes, and their aberrant activities are correlated with several human diseases. Consequently, small molecule HAT and BrD inhibitors with therapeutic potential have been developed. Structural and biochemical studies of HATs and BrDs have revealed that HATs fall into distinct subfamilies containing a structurally related core for cofactor binding, but divergent flanking regions for substrate-specific binding, catalysis, and autoregulation. BrDs adopt a conserved left-handed four-helix bundle to recognize acetyllysine; divergent loop residues contribute to substrate-specific acetyllysine recognition.
Copyright © 2014 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24984779      PMCID: PMC4067988          DOI: 10.1101/cshperspect.a018762

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  162 in total

Review 1.  Modulating molecular functions of p53 with small molecules.

Authors:  Shiraz Mujtaba; Lei Zeng; Ming-Ming Zhou
Journal:  Cell Cycle       Date:  2006-11-15       Impact factor: 4.534

2.  Structure and histone binding properties of the Vps75-Rtt109 chaperone-lysine acetyltransferase complex.

Authors:  Dan Su; Qi Hu; Hui Zhou; James R Thompson; Rui-Ming Xu; Zhiguo Zhang; Georges Mer
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

3.  GCN5-related histone N-acetyltransferases belong to a diverse superfamily that includes the yeast SPT10 protein.

Authors:  A F Neuwald; D Landsman
Journal:  Trends Biochem Sci       Date:  1997-05       Impact factor: 13.807

4.  The TAF(II)250 subunit of TFIID has histone acetyltransferase activity.

Authors:  C A Mizzen; X J Yang; T Kokubo; J E Brownell; A J Bannister; T Owen-Hughes; J Workman; L Wang; S L Berger; T Kouzarides; Y Nakatani; C D Allis
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

5.  MYST protein acetyltransferase activity requires active site lysine autoacetylation.

Authors:  Hua Yuan; Dorine Rossetto; Hestia Mellert; Weiwei Dang; Madhusudan Srinivasan; Jamel Johnson; Santosh Hodawadekar; Emily C Ding; Kaye Speicher; Nebiyu Abshiru; Rocco Perry; Jiang Wu; Chao Yang; Y George Zheng; David W Speicher; Pierre Thibault; Alain Verreault; F Bradley Johnson; Shelley L Berger; Rolf Sternglanz; Steven B McMahon; Jacques Côté; Ronen Marmorstein
Journal:  EMBO J       Date:  2011-10-21       Impact factor: 11.598

6.  Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis.

Authors:  Bokyung Sung; Manoj K Pandey; Kwang Seok Ahn; Tingfang Yi; Madan M Chaturvedi; Mingyao Liu; Bharat B Aggarwal
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

7.  Hif1 is a component of yeast histone acetyltransferase B, a complex mainly localized in the nucleus.

Authors:  Ana Poveda; Mercè Pamblanco; Stefan Tafrov; Vicente Tordera; Rolf Sternglanz; Ramon Sendra
Journal:  J Biol Chem       Date:  2004-02-03       Impact factor: 5.157

8.  Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer.

Authors:  June X Zou; Linlang Guo; Alexey S Revenko; Clifford G Tepper; Abigael T Gemo; Hsing-Jien Kung; Hong-Wu Chen
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

9.  Acetylation of lysine 56 of histone H3 catalyzed by RTT109 and regulated by ASF1 is required for replisome integrity.

Authors:  Junhong Han; Hui Zhou; Zhizhong Li; Rui-Ming Xu; Zhiguo Zhang
Journal:  J Biol Chem       Date:  2007-08-09       Impact factor: 5.157

10.  Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

Authors:  Mark A Dawson; Rab K Prinjha; Antje Dittmann; George Giotopoulos; Marcus Bantscheff; Wai-In Chan; Samuel C Robson; Chun-wa Chung; Carsten Hopf; Mikhail M Savitski; Carola Huthmacher; Emma Gudgin; Dave Lugo; Soren Beinke; Trevor D Chapman; Emma J Roberts; Peter E Soden; Kurt R Auger; Olivier Mirguet; Konstanze Doehner; Ruud Delwel; Alan K Burnett; Phillip Jeffrey; Gerard Drewes; Kevin Lee; Brian J P Huntly; Tony Kouzarides
Journal:  Nature       Date:  2011-10-02       Impact factor: 49.962

View more
  168 in total

Review 1.  Dosage compensation in Drosophila.

Authors:  John C Lucchesi; Mitzi I Kuroda
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-05-01       Impact factor: 10.005

2.  Molecular Coupling of Histone Crotonylation and Active Transcription by AF9 YEATS Domain.

Authors:  Yuanyuan Li; Benjamin R Sabari; Tatyana Panchenko; Hong Wen; Dan Zhao; Haipeng Guan; Liling Wan; He Huang; Zhanyun Tang; Yingming Zhao; Robert G Roeder; Xiaobing Shi; C David Allis; Haitao Li
Journal:  Mol Cell       Date:  2016-04-21       Impact factor: 17.970

Review 3.  Structure, mechanism, and inhibition of the zinc-dependent histone deacetylases.

Authors:  Nicholas J Porter; David W Christianson
Journal:  Curr Opin Struct Biol       Date:  2019-02-08       Impact factor: 6.809

Review 4.  Epigenetic regulation in plants.

Authors:  Craig S Pikaard; Ortrun Mittelsten Scheid
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-12-01       Impact factor: 10.005

Review 5.  50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond.

Authors:  Eric Verdin; Melanie Ott
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12-30       Impact factor: 94.444

Review 6.  Regulation of T cell differentiation and function by epigenetic modification enzymes.

Authors:  Huicheng Liu; Pingfei Li; Zhengping Wei; Cai Zhang; Minghui Xia; Qiuyang Du; Yufei Chen; Na Liu; Huabin Li; Xiang-Ping Yang
Journal:  Semin Immunopathol       Date:  2019-04-08       Impact factor: 9.623

Review 7.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 8.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

9.  Butyrate Reprograms Expression of Specific Interferon-Stimulated Genes.

Authors:  Mahesh Chemudupati; Adam D Kenney; Anna C Smith; Robert J Fillinger; Lizhi Zhang; Ashley Zani; Shan-Lu Liu; Matthew Z Anderson; Amit Sharma; Jacob S Yount
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

Review 10.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.